XML 29 R6.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:    
Net loss $ (15,022,027) $ (15,423,471)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 735 1,284
Stock-based compensation 2,305,849 2,965,938
Interest earned on marketable securities (430,993)
Changes in operating assets and liabilities:    
Prepaid expenses and other current and non-current assets (81,944) 161,800
Accounts payable and other current liabilities 474,057 (680,520)
Operating lease right-of-use asset and liability, net 142 647
Net cash used in operating activities (12,323,188) (13,405,315)
Cash flows from investing activities:    
Purchase of marketable securities (6,859,432)
Maturity of marketable securities 24,000,000
Net cash provided by investing activities 17,140,568
Cash flows from financing activities:    
Proceeds from issuance of shares of common stock and warrants 5,510,591
Issuance costs (762,703)
Net cash provided by financing activities 4,747,888
Net (decrease) increase in cash and cash equivalents (7,575,300) 3,735,253
Cash and cash equivalents at beginning of year 13,362,053 9,626,800
Cash and cash equivalents at end of year 5,786,753 13,362,053
Noncash investing and financing activities    
ASC 842 lease renewal option exercise 236,506
Transaction costs in accounts payable and other current liabilities 163,333
Change in accumulated other comprehensive income (96,434)
Supplemental cash flow disclosures    
Cash paid for income taxes $ 1,600 $ 1,600